Sacha Inchi Protein.

Pea protein is generous in lysine but modest in the sulfur amino acids, while sacha inchi seed protein carries a notably high cysteine and methionine share. Blending the two lifts the limiting amino acid on both sides.

Seed proteins are generally lower in lysine than animal proteins, which caps how much of the rest can be used for protein synthesis. Added free lysine raises the usable share of the blend.

Plant proteins carry a lower leucine share than whey, and leucine is the trigger for the muscle protein synthesis signal. Fortifying a plant protein with free leucine to reach that threshold is standard formulation practice.

Seed proteins sit in a fibre and phytate matrix and carry protease inhibitors, so they hydrolyse more slowly than dairy protein. Added protease raises the amount broken down into absorbable peptides.

Seed derived protein powders carry phytic acid, which chelates divalent minerals and holds them in an unabsorbable complex. Phytase cleaves the phosphate groups and releases those minerals.

Phytate in seed protein binds zinc tightly in the intestine and lowers how much is taken up. Zinc taken away from the protein serving, or a phytase treated protein, avoids the loss.

Phytate and seed polyphenols both chelate non heme iron and are the main reason plant iron is absorbed poorly. Separating the iron dose from the protein serving is the practical answer.

Ascorbate reduces ferric iron to the ferrous form and keeps it soluble against the chelating effect of phytate in a seed protein matrix. It is the standard counter to plant matrix iron binding.

Tryptophan crosses into the brain on the same large neutral amino acid carrier that a protein load floods with branched chain amino acids. A protein serving therefore lowers the share of that carrier tryptophan gets.

Plant seed proteins are typically limited in one or more indispensable amino acids, so blending or supplementing to fill the gap is standard protein complementation. Methionine is the residue most often added on the plant side. The interaction is on amino acid pattern, not on absorption.

Whey is leucine-dense and rapidly digested, while a seed press-cake protein digests more slowly and carries residual fat and fibre. Blends are used to get both a fast amino acid rise and a slower tail. The two do not compete for anything.

Casein clots in the stomach and releases amino acids slowly, and a plant press-cake protein has its own slower profile from its fat and fibre content. Combining them is a formulation choice about release rate. Nothing about the pair changes either protein's amino acid pattern.

Pyridoxal 5-phosphate is the cofactor for transaminases and for most amino acid decarboxylases, so the enzymes that route dietary amino acids into other molecules depend on it. A higher protein intake raises the traffic through those reactions. This is settled biochemistry and needs no trial.

Pyridoxal 5-phosphate is the form the transaminases actually use, so it enters the same amino acid handling reactions without the conversion step pyridoxine requires. The relationship to a protein dose is the same cofactor logic. Form choice here is about the conversion step, not about potency.

Seed press cake retains phytic acid, which binds calcium and other divalent minerals in the gut and lowers the absorbed fraction. That is why phytase is used in plant protein formulas. Taking a calcium dose away from a large seed protein serving reduces the overlap.

Phytate binds magnesium along with the other divalent cations it complexes, reducing the fraction absorbed from a co-eaten dose. The effect belongs to the seed matrix rather than to the protein itself. Dose spacing or added phytase both address it.

Copper is bound by phytate in the same way as other trace divalent minerals, and its absorbed fraction is small to begin with. A phytate-containing press cake taken with a copper supplement is worth separating. This is chemistry of the seed matrix, not of the amino acids.

Manganese binds phytate readily and has low fractional absorption, so a seed-based protein taken alongside can lower it further. The interaction is luminal binding. Timing is the practical handling.

Phytate is the strongest single inhibitor of non-heme iron absorption in plant foods, forming insoluble complexes with iron in the gut. An iron salt taken in the same dose as a seed press-cake protein loses part of its absorbed fraction. Vitamin C in the same dose, or separating the two, both help.

Pepsin performs the first stage of protein hydrolysis in the acidic stomach, cutting intact protein into large peptides that pancreatic enzymes finish. A plant protein arriving in a fibrous matrix depends on that first cut to be accessible. Supplying the enzyme is a digestion-support rationale rather than a measured gain.

Pepsin needs an acidic pH to work, and betaine hydrochloride is used to lower gastric pH where acid output is low. That makes it a companion to a protein dose rather than to the protein's amino acid pattern. It is contraindicated alongside anything that irritates the stomach lining, which is the trade-off.

Bromelain is a plant cysteine protease that hydrolyses seed and dairy proteins readily, and it is used industrially to make protein hydrolysates. Taken with a plant protein it continues that hydrolysis in the gut lumen. The action is on protein breakdown, not on how much protein is in the powder.

Papain is a cysteine protease with broad substrate specificity used in plant protein hydrolysis. Alongside a press-cake protein it targets the same peptide bonds gastric and pancreatic enzymes work on. Enzyme-substrate chemistry is established; a clinical benefit for the pair is not.

Pancreatin supplies the trypsin, chymotrypsin, lipase and amylase mixture that finishes protein and fat digestion at intestinal pH, which suits a press cake carrying both protein and residual oil. It covers two macronutrient streams from one product. No trial has paired it with this protein.

Sacha inchi press cake retains residual oil that is high in polyunsaturated fatty acids, and polyunsaturated fats oxidise readily on exposure to air, heat and light. Mixed tocopherols are the standard chain-breaking antioxidant used to slow that in a powder. This is a shelf-life measure, not a nutritional claim.

Rosemary extract standardised on carnosic acid is a widely used oxidation control in fat-containing food powders and works alongside tocopherols rather than instead of them. In a press-cake protein carrying residual polyunsaturated oil, that is the relevant problem to solve. The purpose is stability of the material in the bag.

The residual oil in sacha inchi material is rich in alpha-linolenic acid, and conversion of alpha-linolenic acid to EPA and further to DHA in humans is limited and competes with linoleic acid for the same desaturase enzymes. Preformed EPA and DHA bypass that bottleneck entirely. The two supply different points on the same pathway rather than duplicating each other.

Conversion of plant alpha-linolenic acid through to DHA is the least efficient step in the sequence, so a preformed DHA source addresses what the plant fatty acid does not reliably reach. Algal DHA is the route used where the diet is plant-based. The relationship is precursor versus end product on one pathway.

Vitamin B12 is produced by bacteria and is absent from plant foods, so a diet built around plant protein needs it from a supplement or fortified source. Pairing it with a plant protein is addressing a gap the protein cannot fill. This is a compositional fact about plant foods, not a claim about the protein.

Taurine is essentially absent from plant material and is synthesised in humans from cysteine, so plant-based intakes rely on endogenous production. That makes it a common companion in plant protein formulas. The pairing addresses a compositional gap, and no combination study has measured it.

Carnitine is synthesised from lysine and methionine with vitamin C, iron and niacin as required cofactors, and dietary carnitine comes mainly from animal foods. A lysine and methionine supply from protein feeds that synthesis, and a direct carnitine source bypasses it. Both routes lead to the same molecule, from different starting points.

HMB is a downstream metabolite of leucine, so a protein dose supplying leucine and an HMB dose sit on the same pathway at different points. Only a small fraction of dietary leucine converts to HMB, which is the rationale for supplying it directly. The pathway relationship is established; a combined effect is not.

Creatine is synthesised from glycine, arginine and methionine and is otherwise obtained from animal foods, so plant-based intakes start from lower muscle stores. A protein dose supplies the precursors and a creatine dose supplies the molecule. They address the same store from two directions.

Beta-alanine is the rate-limiting precursor for muscle carnosine, and its dietary sources are animal foods, so a plant protein does not supply it meaningfully. In a training formula the two cover different jobs, amino acid supply and intramuscular buffering. Neither interferes with the other.

Carnosine is a dipeptide of beta-alanine and histidine, so histidine is the second precursor and it comes from dietary protein. A protein dose contributes it directly. The relationship is precursor to product, and histidine is rarely the limiting one.